The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I dose-escalation and expansion study of JPI-547, a dual inhibitor of PARP/tankyrase in patients with advanced solid tumors.
 
Seock-Ah Im
Consulting or Advisory Role - Amgen; AstraZeneca; Daiichi Sankyo; Eisai; GlaxoSmithKline; Hanmi; Lilly; MSD; Novartis; Pfizer; Roche/Genentech
Research Funding - AstraZeneca (Inst); Daewoong Pharmaceutical (Inst); Eisai (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Other Relationship - Roche
 
SeungHwan Lee
No Relationships to Disclose
 
Keun Wook Lee
Honoraria - BMS; Genexine; Lilly
Consulting or Advisory Role - Bayer; ISU ABXIS
Research Funding - ABL Bio (Inst); ALX Oncology (Inst); Array BioPharma (Inst); AstraZeneca/MedImmune (Inst); BeiGene (Inst); Daiichi Sankyo (Inst); Five Prime Therapeutics (Inst); Green Cross (Inst); LSK BioPharma (Inst); Macrogenics (Inst); Merck KGaA (Inst); MSD (Inst); Oncologie (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Pharmacyclics (Inst); Taiho Pharmaceutical (Inst); Y-BIOLOGICS (Inst); Zymeworks (Inst)
 
Youngjoo Lee
No Relationships to Disclose
 
Joohyuk Sohn
Research Funding - AstraZeneca (Inst); Bayer (Inst); Daiichi Sankyo (Inst); GlaxoSmithKline (Inst); Lilly (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Other Relationship - Roche
 
Jee Hyun Kim
Honoraria - AstraZeneca; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - Bixink; Eisai
Research Funding - Ono Pharmaceutical (Inst)
 
Young-Hyuck Im
No Relationships to Disclose
 
Kyong Hwa Park
Honoraria - Celltrion
 
Do-Youn Oh
Consulting or Advisory Role - ASLAN Pharmaceuticals; AstraZeneca; Basilea; Bayer; BeiGene; Celgene; Genentech/Roche; Halozyme; Merck Serono; Novartis; Taiho Pharmaceutical; Zymeworks
Research Funding - Array BioPharma; AstraZeneca; BeiGene; Lilly; MSD; Novartis; SERVIER
 
Min Hwan Kim
Research Funding - AstraZeneca; Daewoong Pharmaceutical
 
Yeon Hee Park
Honoraria - Merck; Novartis; Pfizer
Consulting or Advisory Role - AstraZeneca; Daiichi-Sankyo; Eisai; Pfizer; Roche
Research Funding - AstraZeneca; Merck; Novartis; Pfizer
Travel, Accommodations, Expenses - Merck; Novartis
 
Tae Min Kim
Consulting or Advisory Role - BeyondBIO; GI CELL; Hanmi
Speakers' Bureau - Takeda
Research Funding - AstraZeneca
(OPTIONAL) Uncompensated Relationships - AstraZeneca/MedImmune; Bayer; Boryung; Novartis; Roche/Genentech; Sanofi
 
Yoon Ji Choi
No Relationships to Disclose
 
Chang-Seok Lee
Employment - Jeil Pharmaceutical Co
Leadership - Jeil Pharmaceutical Co
Stock and Other Ownership Interests - Jeil Pharmaceutical Co
 
Jiseon Park
Employment - Jeil Pharmaceutical Co
Leadership - Jeil Pharmaceutical Co
Stock and Other Ownership Interests - onconic therapeutics
Research Funding - Jeil Pharmaceutical Co (Inst)
Patents, Royalties, Other Intellectual Property - hold Patents (Inst)
 
Nam Seok Baek
No Relationships to Disclose
 
MiKyung CHOI
No Relationships to Disclose
 
John Kim
Employment - onconic therapeutics
 
Eunyoung Yu
Employment - onconic therapeutics
 
Yung-Jue Bang
Consulting or Advisory Role - Astellas Pharma; AstraZeneca/MedImmune; BeiGene; Bristol-Myers Squibb; Daiichi Sankyo; Genentech/Roche; Green Cross; Hanmi; Merck Serono; MSD Oncology; Novartis; Samyang
Research Funding - Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Curis (Inst); Daiichi Sankyo (Inst); Genentech/Roche (Inst); Genexine (Inst); GlaxoSmithKline (Inst); Green Cross (Inst); Lilly (Inst); Merck Serono (Inst); MSD (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)